These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12539678)

  • 1. [Preparation of cucurbitacinBE polylactic acid nano-particles for targeting cervical lymph nodes].
    Yang K; Wen Y; Li L; Wang C; Hou S; Li C
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Dec; 19(6):347-50. PubMed ID: 12539678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical application of anticancer nanoparticles targeting metastasis foci of cervical lymph nodes in patients with oral carcinoma].
    Yang K; Wen Y; Wang C
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Dec; 21(6):447-50. PubMed ID: 14732978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute toxicity and local stimulate test of cucurbitacinBE polylactic acid nano-particles of targeting cervical lymph nodes].
    Yang K; Wen Y; Li L; Wang C; Wang X
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Dec; 19(6):380-2. PubMed ID: 12539689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The study of cucurbitacin BE polylactic acid nanoparticles delivering cucurbitacin BE to metastasized cervical lymph nodes in mice with oral cancer].
    Yang K; Wen Y; Wang C
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Dec; 21(6):477-80. PubMed ID: 14732987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and release efficiency of polylactic acid nanoparticle].
    Huang KH; Zhu ZH; Liu JH; Chen QK; Liu XY; Chang J
    Ai Zheng; 2005 Aug; 24(8):1023-6. PubMed ID: 16086887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of cisplatin loaded polylactic acid-polyethylene glycol nano-particles for targeting oral carcinoma].
    Yang K; Chen SW; Chen R; Wan YM
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2005 Oct; 23(5):445-8. PubMed ID: 16285559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseases.
    Freitas MN; Marchetti JM
    Int J Pharm; 2005 May; 295(1-2):201-11. PubMed ID: 15848005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of lymphatic targeting dosage form: pingyangmycin absorbed on activated carbon nanoparticles].
    Sun ML; Wen YM; Wang CM; Li LJ; Wang XY
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Jun; 22(3):183-5. PubMed ID: 15293458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on lyophilization injection of cucurbitacin polylactic acid nanoparticles].
    Li CY; Hou SX
    Zhongguo Zhong Yao Za Zhi; 2001 May; 26(5):315-7. PubMed ID: 12528519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of drug-loaded polylactic acid nanospheres and drug-releasing performance evaluation].
    Li L; Li GM; Huang WH
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):352-4. PubMed ID: 15041563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in autologous human fat transplant survival with SVF plus VEGF-PLA nano-sustained release microspheres.
    Li L; Pan S; Ni B; Lin Y
    Cell Biol Int; 2014 Aug; 38(8):962-70. PubMed ID: 24740717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of therapeutic efficacy of bleomycin by incorporation into biodegradable poly-d,l-lactic acid.
    Kumanohoso T; Natsugoe S; Shimada M; Aikou T
    Cancer Chemother Pharmacol; 1997; 40(2):112-6. PubMed ID: 9182831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the rifampicin polylactic acid microspheres for lung targeting].
    Zhang W; Jiang X; Zhu C; Hu J
    Yao Xue Xue Bao; 1998; 33(1):57-61. PubMed ID: 11938937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The preparation of the polylacticacid nanoparticles of cucurbitacin and their drug loading].
    Zhang JF; Hou SX; Liu HL; Wang L; Hu P; Ye LM; Wang GS
    Zhongguo Zhong Yao Za Zhi; 2005 Mar; 30(6):436-9. PubMed ID: 15810448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of polylactic acid particles and release of fluorochromes upon topical application on human skin explants.
    Rancan F; Todorova A; Hadam S; Papakostas D; Luciani E; Graf C; Gernert U; Rühl E; Verrier B; Sterry W; Blume-Peytavi U; Vogt A
    Eur J Pharm Biopharm; 2012 Jan; 80(1):76-84. PubMed ID: 21945270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A basic study on usefulness of bleomycin incorporated in poly DL-lactic acid].
    Kumanohoso T; Natsugoe S; Shimada M; Sagara M; Aikou T; Shimazu H; Shinkawa T; Nakamura K; Fukuzaki H
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1572-4. PubMed ID: 7690536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Particle characteristics and lung deposition patterns in a human airway replica of a dry powder formulation of polylactic acid produced using supercritical fluid technology.
    Cheng YS; Yazzie D; Gao J; Muggli D; Etter J; Rosenthal GJ
    J Aerosol Med; 2003; 16(1):65-73. PubMed ID: 12737686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.
    Kim HK; Park TG
    J Control Release; 2004 Jul; 98(1):115-25. PubMed ID: 15245894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation and toxicity of triptolide-loaded poly (D,L-lactic acid) nanoparticles].
    Liu MX; Dong J; Yang YJ; Yang XL; Xu HB
    Yao Xue Xue Bao; 2004 Jul; 39(7):556-60. PubMed ID: 15493850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.